Cotte FE - Search Results

1

A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France.

Casabianca P, Massetti M, Cotte FE, Moreau R, Kassahun S, Singh P, Kim I, Gaudin AF, Piessen G, Leleu H. Casabianca P, et al. Among authors: cotte fe. Pharmacoecon Open. 2024 Sep;8(5):689-699. doi: 10.1007/s41669-024-00500-y. Epub 2024 Jul 4. Pharmacoecon Open. 2024. PMID: 38965151 Free PMC article.

2

Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France.

Bregman B, Teitsson S, Orsini I, Cotté FE, Amadi A, Moshyk A, Roze S, Gaudin AF. Bregman B, et al. Among authors: cotte fe. Dermatol Ther (Heidelb). 2020 Dec;10(6):1331-1343. doi: 10.1007/s13555-020-00446-z. Epub 2020 Sep 13. Dermatol Ther (Heidelb). 2020. PMID: 32920709 Free PMC article.

3

Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.

Grumberg V, Chouaïd C, Cotté FE, Jouaneton B, Jolivel R, Gaudin AF, Reynaud D, Assié JB, Borget I. Grumberg V, et al. Among authors: cotte fe. J Med Econ. 2022 Jan-Dec;25(1):691-699. doi: 10.1080/13696998.2022.2079291. J Med Econ. 2022. PMID: 35587018 Free article.

4

Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.

Cotté FE, Chaize G, Kachaner I, Gaudin AF, Vainchtock A, Durand-Zaleski I. Cotté FE, et al. J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e73-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.022. Epub 2013 Oct 8. J Stroke Cerebrovasc Dis. 2014. PMID: 24119623

5

Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis.

Assié JB, Grumberg V, Reynaud D, Gaudin AF, Batisse A, Jolivel R, Jouaneton B, Cotté FE, Chouaïd C. Assié JB, et al. Among authors: cotte fe. Respir Med Res. 2023 Nov;84:101051. doi: 10.1016/j.resmer.2023.101051. Epub 2023 Oct 6. Respir Med Res. 2023. PMID: 37897879 Free article.

6

Burden Of Cardiovascular Complications In Patients With Atrial Fibrillation In France.

Fauchier L, Samson A, Chaize G, Gaudin AF, Vainchtock A, Bailly C, Cotté FE. Fauchier L, et al. Among authors: cotte fe. Value Health. 2014 Nov;17(7):A483. doi: 10.1016/j.jval.2014.08.1404. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201414 Free article. No abstract available.

7

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis.

Giaj Levra M, Cotté FE, Corre R, Calvet C, Gaudin AF, Penrod JR, Grumberg V, Jouaneton B, Jolivel R, Assié JB, Chouaïd C. Giaj Levra M, et al. Among authors: cotte fe. Lung Cancer. 2020 Feb;140:99-106. doi: 10.1016/j.lungcan.2019.12.017. Epub 2019 Dec 31. Lung Cancer. 2020. PMID: 31911324 Free article.

8

Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations.

Wilczynski O, Boisbouvier A, Radoszycki L, Cotté FE, Gaudin AF, Lemasson H. Wilczynski O, et al. Among authors: cotte fe. J Med Internet Res. 2022 Jan 11;24(1):e25792. doi: 10.2196/25792. J Med Internet Res. 2022. PMID: 35014969 Free PMC article.

9

Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Chouaïd C, Grumberg V, Batisse A, Corre R, Giaj Levra M, Gaudin AF, Prodel M, Lortet-Tieulent J, Assié JB, Cotté FE. Chouaïd C, et al. Among authors: cotte fe. JCO Clin Cancer Inform. 2022 Feb;6:e2100108. doi: 10.1200/CCI.21.00108. JCO Clin Cancer Inform. 2022. PMID: 35113656 Free PMC article.

10

Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.

Assié JB, Chouaïd C, Nunes H, Reynaud D, Gaudin AF, Grumberg V, Jolivel R, Jouaneton B, Cotté FE, Duchemann B. Assié JB, et al. Among authors: cotte fe. Ther Adv Med Oncol. 2023 Jan 31;15:17588359231152847. doi: 10.1177/17588359231152847. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36743523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters